Collaborative Research Program. As from the Effective Date, ADDEX and OMP, by themselves or through their Affiliates or on behalf of OMP by Xxxxxxx & Xxxxxxx Pharmaceutical Research and Development, a division of XXXXXXX Pharmaceutica N.V., will each conduct their part of the Research, in accordance with the Research Program, on a collaborative basis with a goal of discovering, identifying and synthesizing Collaboration Compounds that are suitable for development into Collaboration Products. To facilitate the Research ADDEX will transfer within [***] calendar days of the Effective Date to OMP any cells, cell-lines, research tools or materials necessary performing the screening assays described in Appendix B. The initial Research Program shall be mutually agreed upon between the Parties and attached hereto as Appendix A. Parties acknowledge that the initial primary focus of the Research Program is to identify Collaboration Compounds with potential for treatment or prevention of diseases and disabilities related to the central nervous system. However Parties equally acknowledge that mGlu2-R may play an important role with respect to other diseases and disabilities than those related to the central nervous system. Hence, Parties acknowledge that the eventual Development of a Collaboration Compound may include other indications
Collaborative Research Program. 4.1 The parties shall, within [*] days from the Effective Date negotiate in good faith a collaborative research program agreement.
Collaborative Research Program. 2.1.1 Purpose Myco and Pfizer shall conduct the Research Program throughout the Contract Period. The objective of the Research Program is to discover and develop Products.
Collaborative Research Program. 22 5.1 Research Program Objectives..................................22 5.2 Annual Research Plans........................................23 5.3 Research Projects............................................24 5.4 Termination of a Research Project............................29 5.5 Research Program.............................................29
Collaborative Research Program. 5.1 Research Program Objectives
(a) The overall objective of the Research Program is to develop Diagnostic Products that accurately establish a patient's current diagnosis, predict future risk of disease, predict drug response and determine responses to treatment or the health status of individuals; as part of the primary objective, the Parties also intend:
(i) To develop IT Products which support the marketing of the other Products developed under the other Research Projects (e.g., to create software programs and algorithms that provide decision support for the other Products);
(ii) To develop algorithms for establishing diagnostic patterns;
(iii) To develop stand-alone IT Products which aid in medical decision making;
(iv) To create a diagnostics-focused database to be used for both discovery applications and post marketing studies (e.g., such a database might combine key datasets from [CONFIDENTIAL TREATMENT REQUESTED]; and
(v) To develop IT Products which use databases (including the database which may be developed under this Agreement) for aiding in medical decision support.
(b) The Parties intend to achieve the objectives set forth in subsection (a) above by allocating the responsibilities between the Parties in any Annual Research Plan and seek to leverage the core strengths of each of Roche and deCODE including the following:
(i) With respect to Roche, its core strengths in the areas of DNA/RNA/proteomics-testing platform, nucleic acid-based diagnostic markers, disease-causing genes and polymorphisms, diagnostic development and commercialization know-how, marketing and distribution capabilities, registration, quality and manufacturing know-how, cash resources and therapies to support diagnostic decisions.
(ii) With respect to deCODE, its core strength in the areas of identification of disease-causing genes and polymorphisms, know-how for other potential predictors (expression-based, haplotypes, familial analysis), access to population-based medical data and samples, bioinformatics, statistics, genealogy, and associated genealogy software, privacy and decision support software, and mathematical algorithms for use in data mining.
Collaborative Research Program. 23 5.1 Exclusivity ...................................................... 23 5.2 Diseases ......................................................... 23 5.3
Collaborative Research Program. Subject to the terms and conditions set forth herein. Warner and Sequana will diligently conduct mutually agreed collaborative research in the Field pursuant to a Research Plan (the "Research Program"). The activities conducted in connection with the Research Program will be overseen and administered by the JRPC.
Collaborative Research Program. Commencing on the Effective Date, the Parties shall conduct the Research diligently on a collaborative basis, with the goal of discovering, identifying and performing pre-clinical research on Collaboration Compounds that are suitable for developing as Collaboration Products for commercialization as soon as reasonably practicable. The Parties shall conduct the Research as generally specified in the Research Plan, attached hereto as Exhibit A, as such plan may be amended from time to time by the JRC. The Research Plan, among other things, shall specify scientific direction and Research milestones and allocate Research responsibilities and resources in a manner consistent with this Agreement.
Collaborative Research Program. 2.1 OSI/Bayer Annual Operating Plan and Budget. The OSI/Bayer Annual Operating Plan and Budget for the initial Commitment Year is set forth in Exhibit B and attached hereto. For each Commitment Year after the initial Commitment Year, the OSI/Bayer Annual Operating Plan and Budget shall be prepared by the Joint Management Committee no later than ninety (90) days before the end of the prior Commitment Year. The OSI/Bayer Annual Operating Plan and Budget for each Commitment Year shall be appended to and made part of this Agreement.
Collaborative Research Program. ACT and PRI agree that they will conduct the Research on a collaborative basis with a goal of discovering, identifying and synthesizing Collaboration Products that are suitable for development into Product for commercialization. The Parties have agreed to an initial Research Plan, as described in Exhibit A attached hereto.